Nearly all individuals with syndrome develop type 2 diabetes (125853), suggesting that ALMS1 may be involved in 'diabesity,' a term used by Collin et al. (2002) [14] for combined obesity and diabetes susceptibility due to altered function of a single gene. This evidence concerns the gene ALMS1 and obesity due to melanocortin 4 receptor deficiency.